CN1107342A - "Yixinkang" medicine for treatment of heart disease - Google Patents
"Yixinkang" medicine for treatment of heart disease Download PDFInfo
- Publication number
- CN1107342A CN1107342A CN 94108959 CN94108959A CN1107342A CN 1107342 A CN1107342 A CN 1107342A CN 94108959 CN94108959 CN 94108959 CN 94108959 A CN94108959 A CN 94108959A CN 1107342 A CN1107342 A CN 1107342A
- Authority
- CN
- China
- Prior art keywords
- heart disease
- yixinkang
- medicine
- treatment
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese patent medicine "Yixinkang" for improving physical quality of middle-aged and old people and preventing coronary heart disease with obvious effect (78.47% total effective rate) is prepared with ginseng, fleece flower root, notoginseng and haw.
Description
The invention belongs to technical field of Chinese medicines, relate to and a kind of middle-aged and elderly people Blood stasis, blood fat disease are had good improvement effect, the " Yixinkang " medicine for treatment of heart disease and the preparation method of prevention coronary heart disease.
The FUFANG DANSHEN PIAN total effective rate 56.8% of existing treatment middle-aged and elderly people Blood stasis, curative effect is lower.
The objective of the invention is to develop a kind of medicine that has good improvement effect, curative effect to improve to middle-aged and elderly people Blood stasis blood fat disease.
The technical solution used in the present invention is, selects Chinese medicines such as Radix Ginseng, Radix Polygoni Multiflori, Radix Notoginseng, Fructus Crataegi for use, by containing Radix Ginseng 3-10%, and Radix Polygoni Multiflori 15-60%, Radix Notoginseng 8-25%, the proportioning of Fructus Crataegi 18-60% forms through processing and fabricating.
" Yixinkang " medicine for treatment of heart disease of the present invention is mainly used in blood circulation promoting and blood stasis dispelling, tonifying QI to produce body fluid, diseases such as treatment thoracic obstruction pain, numb limbs and tense tendons, spiritlessness and weakness, senilism, hyperlipemia, prevention coronary heart disease.
Benefit heart health tablet is through Henan Prov. Inst. of Chinese Medicine ﹠ Pharmacology, Henan College Of Traditional Chinese Medicine teaching hospital, the Yellow River central hospital clinical observation test (attached clinical report), symptom curative effect total effective rate 78.47%, matched group 56.8%, very notable difference is arranged, hemorheological indexes all has highly significant difference, blood fat curative effect cholesterol and high density lipoprotein all have utmost point significant difference, and immunologic function and aging relevant enzyme have regulating action, can prevent coronary heart disease, heart disease.
In conjunction with example formulations, further introduce feature of the present invention.
One of prescription, Radix Ginseng 3%, Radix Polygoni Multiflori Preparata 15%, Radix Notoginseng 25%, Fructus Crataegi 57%;
Two of prescription, Radix Ginseng 10%, Radix Polygoni Multiflori Preparata 60%, Radix Notoginseng 8%, Fructus Crataegi 22%;
Three of prescription, Radix Ginseng 10%, Radix Polygoni Multiflori Preparata 20%, Radix Notoginseng 10%, Fructus Crataegi 60%;
Four of prescription, Radix Ginseng 10%, Radix Polygoni Multiflori Preparata 50%, Radix Notoginseng 22%, Fructus Crataegi 18%.
Claims (2)
1, a kind of " Yixinkang " medicine for treatment of heart disease that is used for blood circulation promoting and blood stasis dispelling, tonifying QI to produce body fluid is characterized in that containing Radix Ginseng, Radix Polygoni Multiflori, Radix Notoginseng, Fructus Crataegi, processes according to a certain ratio;
2, " Yixinkang " medicine for treatment of heart disease as claimed in claim 1 is characterized in that described each medicament contg proportioning is 3-10%: 15-60%: 8-25%: 18-60%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94108959 CN1107342A (en) | 1994-08-08 | 1994-08-08 | "Yixinkang" medicine for treatment of heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94108959 CN1107342A (en) | 1994-08-08 | 1994-08-08 | "Yixinkang" medicine for treatment of heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1107342A true CN1107342A (en) | 1995-08-30 |
Family
ID=5033697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 94108959 Pending CN1107342A (en) | 1994-08-08 | 1994-08-08 | "Yixinkang" medicine for treatment of heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1107342A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102225107A (en) * | 2011-06-22 | 2011-10-26 | 河南省中医药研究院 | Yixin xuezhikang capsule |
-
1994
- 1994-08-08 CN CN 94108959 patent/CN1107342A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102225107A (en) * | 2011-06-22 | 2011-10-26 | 河南省中医药研究院 | Yixin xuezhikang capsule |
| CN102225107B (en) * | 2011-06-22 | 2013-06-12 | 河南省中医药研究院 | Yixin xuezhikang capsule |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102895349A (en) | Traditional Chinese medicine tea for treating hypertension, hyperlipidemia and hyperglycemia | |
| CN101670011A (en) | Medicament for treating rheumatism and rheumatoid and preparation method thereof | |
| CN102727711B (en) | Traditional Chinese medicine used for treating chronic fatigue syndrome | |
| CN1994411A (en) | Medicine for treating cerebral apoplexy | |
| CN102698093B (en) | Chinese medicinal composition for treating liver and kidney deficiency type hypertension and preparation method thereof | |
| CN103599455B (en) | Traditional Chinese medicine capsule for removing freckle | |
| CN101032598A (en) | Expectorant cough suppressant and anti-asthmatic healthy wine | |
| CN1101199C (en) | Chinese-medicinal capsule for treating hyperlipomia | |
| CN1107342A (en) | "Yixinkang" medicine for treatment of heart disease | |
| CN1169546C (en) | Chinese medicine for treating hypotension | |
| CN108578603B (en) | Traditional Chinese medicine compound for treating kidney deficiency and marrow depletion type knee osteoarthritis based on shaoyang bone governing theory and application thereof | |
| CN1138559C (en) | Pill medicine for treating cardio-cerebro vascular diseases | |
| CN106138749A (en) | A kind of Herba Dendrobii medicated wine and preparation method | |
| CN105343675A (en) | Traditional Chinese medicine preparation for treating adiposis and preparation method thereof | |
| CN112076268A (en) | Traditional Chinese medicine lotion for preventing and treating alopecia and blackening hair, preparation method and application | |
| CN1621075A (en) | Chinese herbal composition for purifying and nourishing human body internal organ and its application | |
| CN103393850B (en) | Drug for median nerve injury | |
| CN103520647B (en) | A kind of adjustment hyperlipidemia Chinese medicine preparation | |
| CN1185007C (en) | Blood-lipid-reducing thrombolytic medicine | |
| CN116077573A (en) | Traditional Chinese medicine for dredging channels and collaterals and preparation method thereof | |
| CN1528430A (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN111671821A (en) | Formula of health-care product for improving osteoporosis | |
| CN105194202B (en) | A kind of drug for treating liver-kidney yin deficiency premonitory apoplexy | |
| CN1067559C (en) | Syrup for curing cold syndrome in women's lower abdomen, and method for preparing same | |
| CN103405648B (en) | External care substance for ulnar nerve injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |